These molecules reduce oxidative stress in the tumor microenvironment of oral cancer by targeting the MAOB protein. Further drug modifications aim to minimize toxicity and develop a low-toxicity therapeutic strategy for oral cancer treatment. The gene discussed is MAOB; the disease is neoplasm.